Ling Xi

1.1k total citations
32 papers, 753 citations indexed

About

Ling Xi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ling Xi has authored 32 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 8 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Ling Xi's work include Cancer, Hypoxia, and Metabolism (5 papers), Ferroptosis and cancer prognosis (3 papers) and Ubiquitin and proteasome pathways (3 papers). Ling Xi is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Ferroptosis and cancer prognosis (3 papers) and Ubiquitin and proteasome pathways (3 papers). Ling Xi collaborates with scholars based in China, United States and Türkiye. Ling Xi's co-authors include Ding Ma, Jianfeng Zhou, Kezhen Li, Dan He, Liming Wang, Lan Yu, Xiaohui Jiang, Da Zhu, Hui Shen and Zheng Hu and has published in prestigious journals such as Nature Communications, Biochemical and Biophysical Research Communications and Journal of Controlled Release.

In The Last Decade

Ling Xi

28 papers receiving 746 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ling Xi China 17 506 166 121 94 89 32 753
Detian Yuan China 14 549 1.1× 137 0.8× 135 1.1× 87 0.9× 77 0.9× 19 859
Sonali P. Barwe United States 20 714 1.4× 206 1.2× 97 0.8× 119 1.3× 60 0.7× 66 1.1k
Shih-Han Kao Taiwan 12 419 0.8× 112 0.7× 152 1.3× 51 0.5× 82 0.9× 22 595
Maike Busch Germany 13 465 0.9× 208 1.3× 148 1.2× 78 0.8× 35 0.4× 40 819
He Xu China 7 340 0.7× 134 0.8× 106 0.9× 125 1.3× 91 1.0× 15 773
Ridha Limame Belgium 12 453 0.9× 265 1.6× 273 2.3× 76 0.8× 43 0.5× 17 774
Chunxiao Wu China 20 747 1.5× 135 0.8× 247 2.0× 102 1.1× 50 0.6× 54 1.1k
Jianhua Chen China 15 376 0.7× 132 0.8× 116 1.0× 81 0.9× 71 0.8× 33 630
Daofeng Tian China 18 459 0.9× 125 0.8× 232 1.9× 113 1.2× 110 1.2× 47 862

Countries citing papers authored by Ling Xi

Since Specialization
Citations

This map shows the geographic impact of Ling Xi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Xi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Xi more than expected).

Fields of papers citing papers by Ling Xi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Xi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Xi. The network helps show where Ling Xi may publish in the future.

Co-authorship network of co-authors of Ling Xi

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Xi. A scholar is included among the top collaborators of Ling Xi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Xi. Ling Xi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Huaxi, Danya Zhang, Yu Zhang, et al.. (2025). TMTP1-modified nanocarrier boosts cervical cancer immunotherapy by eliciting pyroptosis. Theranostics. 15(11). 5420–5439. 1 indexed citations
2.
Chen, Yuxin, Danya Zhang, Jie Li, et al.. (2025). SNS‑032 combined with decitabine induces caspase‑3/gasdermin E‑dependent pyroptosis in breast cancer cells. Oncology Letters. 29(4). 1–13.
3.
4.
5.
Wang, Xueqian, Guiying Jiang, Danya Zhang, et al.. (2023). A TMVP1-modified near-infrared nanoprobe: molecular imaging for tumor metastasis in sentinel lymph node and targeted enhanced photothermal therapy. Journal of Nanobiotechnology. 21(1). 130–130. 19 indexed citations
6.
Sun, Yue, et al.. (2023). Small Leucine-Rich Proteoglycan PODNL1 Identified as a Potential Tumor Matrix-Mediated Biomarker for Prognosis and Immunotherapy in a Pan-Cancer Setting. Current Issues in Molecular Biology. 45(7). 6116–6139. 4 indexed citations
7.
Miao, Ji, et al.. (2023). circSKA3 promotes colorectal cancer metastases through miR-1238 and methylation. Molecular and Cellular Biochemistry. 479(4). 941–950. 1 indexed citations
8.
Wang, Ling, Danya Zhang, Fei Li, et al.. (2021). A novel ICG-labeled cyclic TMTP1 peptide dimer for sensitive tumor imaging and enhanced photothermal therapy in vivo. European Journal of Medicinal Chemistry. 227. 113935–113935. 21 indexed citations
9.
Gao, Peipei, Ting Peng, Shitong Lin, et al.. (2021). Key Role of MCUR1 in Malignant Progression of Breast Cancer. OncoTargets and Therapy. Volume 14. 4163–4175. 5 indexed citations
10.
Gao, Peipei, Ting Peng, Canhui Cao, et al.. (2021). Association of CLDN6 and CLDN10 With Immune Microenvironment in Ovarian Cancer: A Study of the Claudin Family. Frontiers in Genetics. 12. 595436–595436. 17 indexed citations
11.
Chen, Pingbo, Beibei Wang, Qingqing Mo, et al.. (2019). The LIV-1-GRPEL1 axis adjusts cell fate during anti-mitotic agent-damaged mitosis. EBioMedicine. 49. 26–39. 5 indexed citations
12.
Zou, Chenming, Guiying Jiang, Xueqin Gao, et al.. (2019). Targeted co-delivery of Trp-2 polypeptide and monophosphoryl lipid A by pH-sensitive poly (β-amino ester) nano-vaccines for melanoma. Nanomedicine Nanotechnology Biology and Medicine. 22. 102092–102092. 18 indexed citations
13.
Liu, Dan, Xiaoxue Zhang, Mengchen Li, et al.. (2018). C/EBPβ enhances platinum resistance of ovarian cancer cells by reprogramming H3K79 methylation. Nature Communications. 9(1). 1739–1739. 90 indexed citations
14.
Xi, Ling, et al.. (2016). Regulation of cell apoptosis and proliferation in pancreatic cancer through PI3K/Akt pathway via Polo-like kinase 1. Oncology Reports. 36(1). 49–56. 59 indexed citations
15.
Liu, Ronghua, Xiangyi Ma, Hongyan Wang, et al.. (2013). The novel fusion protein sTRAIL-TMTP1 exhibits a targeted inhibition of primary tumors and metastases. Journal of Molecular Medicine. 92(2). 165–175. 20 indexed citations
16.
Xi, Ling. (2012). Research on Number Optimization of Ticket Checking Gates in Station based on Queuing Theory. 1 indexed citations
17.
Liu, Ronghua, Ling Xi, Danfeng Luo, et al.. (2012). Enhanced targeted anticancer effects and inhibition of tumor metastasis by the TMTP1 compound peptide TMTP1-TAT-NBD. Journal of Controlled Release. 161(3). 893–902. 39 indexed citations
18.
Han, Xiaobing, Ling Xi, Hui Wang, et al.. (2008). The potassium ion channel opener NS1619 inhibits proliferation and induces apoptosis in A2780 ovarian cancer cells. Biochemical and Biophysical Research Communications. 375(2). 205–209. 42 indexed citations
19.
Han, Xiaobing, Fang Wang, Hui Xing, et al.. (2007). Heat shock proteins and p53 play a critical role in K+ channel-mediated tumor cell proliferation and apoptosis. APOPTOSIS. 12(10). 1837–1846. 40 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Detian Yuan Breakdown of academic impact, for papers by Sonali P. Barwe Breakdown of academic impact, for papers by Shih-Han Kao Breakdown of academic impact, for papers by Maike Busch Breakdown of academic impact, for papers by He Xu Breakdown of academic impact, for papers by Ridha Limame Breakdown of academic impact, for papers by Chunxiao Wu Breakdown of academic impact, for papers by Jianhua Chen Breakdown of academic impact, for papers by Daofeng Tian
Rankless by CCL
2026